EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema

Kim Lien Huber, Heiko Stino, Irene Steiner, Philipp Fuchs, Felix Goldbach, Julia Mai, Bianca S Gerendas, Katharina Kriechbaum, Ursula Schmidt-Erfurth, Andreas Pollreisz

Investigative Ophthalmology & Visual Science · 31.12.2024 · 65 (14) · 46

DOI: 10.1167/iovs.65.14.46 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 31.12.2024. Verfasst von Kim Lien Huber und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical University of Vienna, Department of Ophthalmology, Vienna, Austria. Hauptthemen laut MEDLINE: Macular Edema, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Diabetic Retinopathy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsDiabetic RetinopathyIntravitreal InjectionsVisual AcuityAngiogenesis InhibitorsTomography, Optical CoherenceHumansRetrospective StudiesMaleFemaleMiddle AgedAgedTreatment OutcomeDrug SubstitutionVascular Endothelial Growth Factor AFollow-Up Studies

Substanzen

afliberceptReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsAngiogenesis InhibitorsVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • Medical University of Vienna, Department of Ophthalmology, Vienna, Austria.
  • Medical University of Vienna, Center for Medical Data Science, Institute of Medical Statistics, Vienna, Austria.

Zitieren

APA

Huber, K. L., Stino, H., Steiner, I., Fuchs, P., Goldbach, F., Mai, J., Gerendas, B. S., Kriechbaum, K., Schmidt-Erfurth, U., & Pollreisz, A. (2024). Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema. Investigative Ophthalmology & Visual Science, 65(14), 46. https://doi.org/10.1167/iovs.65.14.46

Vancouver

Huber KL, Stino H, Steiner I, Fuchs P, Goldbach F, Mai J, et al. Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 2024;65(14):46. doi:10.1167/iovs.65.14.46

BibTeX
@article{Huber2024,
  author = {Huber, Kim Lien and Stino, Heiko and Steiner, Irene and Fuchs, Philipp and Goldbach, Felix and Mai, Julia and Gerendas, Bianca S and Kriechbaum, Katharina and Schmidt-Erfurth, Ursula and Pollreisz, Andreas},
  title = {Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2024},
  volume = {65},
  number = {14},
  pages = {46},
  doi = {10.1167/iovs.65.14.46}
}
Kostenlos starten →